SIEN SEC-arkivering - Sientra, Inc.- Årsrapport, fuldmagtserklæring, prospekt

Grundlæggende statistik

LEI	5493006T0OLHI64MOG63
CIK	1551693

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Sientra, Inc.

SEC Filings (Chronological Order)

Denne side giver en komplet, kronologisk liste over SEC-arkiveringer, eksklusive ejerskabsregistreringer, som vi leverer andre steder.

June 25, 2024	EX-2.2	IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE Exhibit 2.2 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE ) In re: ) Chapter 11 ) PROJECT SAGE M HOLDINGS OLDCO, INC., ) Case No. 24-10245 (JTD) et al.,1 ) ) (Jointly Administered) Debtors. ) ) Re: Docket Nos. 380, 430, 434 FINDINGS OF fACT, CONCLUSIONS OF LAW, AND order APPROVING THE DEBTORS’ SECOND AMENDED COMBINED DISCLOSURE STATEMENT AND JOINT PLAN OF Project sage oldco, i
June 25, 2024	8-K	Bankruptcy or Receivership, Material Modification to Rights of Security Holders, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES ACT OF 1934 Date of Report (Date of earliest event reported): June 18, 2024 PROJECT SAGE OLDCO, INC. (Exact name of registrants as specified in its charters) Delaware 001-36709 20-5551000 (State or other jurisdiction of incorporation or organization) (Co
June 25, 2024	15-12G	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-36709 Project Sage Oldco, Inc. (Exact name of registrant as specified in
June 25, 2024	EX-2.1	IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE Exhibit 2.1 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE ) In re: ) Chapter 11 ) PROJECT SAGE M HOLDINGS OLDCO, INC., ) Case No. 24-10245 (JTD) et al.,1 ) ) Debtors. ) (Jointly Administered) ) SECOND AMENDED COMBINED DISCLOSURE STATEMENT AND JOINT PLAN OF PROJECT SAGE OLDCO, INC. AND ITS AFFILIATED DEBTORS UNDER CHAPTER 11 OF THE BANKRUPTCY CODE THIS CHAPTER 11 PLAN IS BEING
April 29, 2024	8-K	Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES ACT OF 1934 Date of Report (Date of earliest event reported): April 24, 2024 SIENTRA, INC. (Exact name of registrants as specified in its charters) Delaware (State or other jurisdiction of incorporation or organization) 001-36709 (Commission File Number)
April 18, 2024	EX-2.2	FIRST AMENDMENT TO ASSET PURCHASE AGREEMENT Exhibit 2.2 FIRST AMENDMENT TO ASSET PURCHASE AGREEMENT THIS FIRST AMENDMENT TO ASSET PURCHASE AGREEMENT (this “Amendment”), dated as of April 16, 2024 (the “Effective Date”), is entered into by and among Tiger Aesthetics Medical, LLC, a Delaware limited liability company (the “Buyer”), on the one hand, and Sientra, Inc., a Delaware corporation (“Sientra”), Mist Holdings, Inc., a Delaware corporat
April 18, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES ACT OF 1934 Date of Report (Date of earliest event reported): April 18, 2024 SIENTRA, INC. (Exact name o UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES ACT OF 1934 Date of Report (Date of earliest event reported): April 18, 2024 SIENTRA, INC. (Exact name of registrants as specified in its charters) Delaware (State or other jurisdiction of incorporation or organization) 001-36709 (Commission File Number)
April 18, 2024	EX-2.1	ASSET PURCHASE AGREEMENT Exhibit 2.1 ASSET PURCHASE AGREEMENT THIS ASSET PURCHASE AGREEMENT (the “Agreement”) is made and entered into as of this 4th day of April, 2024, by and between Tiger Aesthetics Medical, LLC, a Delaware limited liability company (the “Buyer”), on the one hand, and Sientra, Inc., a Delaware corporation (“Sientra”), Mist Holdings, Inc., a Delaware corporation, Mist, Inc., a Delaware corporation and M
April 18, 2024	EX-2.3	ASSET PURCHASE AGREEMENT Exhibit 2.3 ASSET PURCHASE AGREEMENT THIS ASSET PURCHASE AGREEMENT (the “Agreement”) is made and entered into as of this 28th day of March, 2024, by and between Nuance Intermediary, LLC, a Delaware limited liability company (the “Buyer”), on the one hand, and Sientra, Inc., a Delaware corporation, Mist Holdings, Inc., a Delaware corporation, Mist, Inc., a Delaware corporation, and Mist Internation
March 29, 2024	NT 10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one):  Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-CEN ¨ Form N-CSR For Period Ended: December 31, 2023 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q For Transition Period
February 20, 2024	SC 13G/A	SIEN / Sientra, Inc. / Rosalind Advisors, Inc. Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A (Amendment No: 01) Under the Securities Exchange Act of 1934 Sientra, Inc. (Name of Issuer) Common Shares (Title of Class of Securities) 82621J204 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whic
February 20, 2024	EX-99.A BD-DIR-RESOL	Joint Filing Agreement EX-99.A BD-DIR-RESOL 2 rosalindsienexa02-19-.htm Exhibit A Joint Filing Agreement The undersigned hereby agree that this Statement on Schedule 13G/A with respect to the beneficial ownership of shares of Common Stock of Sientra, Inc. is filed jointly on behalf of each of them. Rosalind Advisors, Inc. By: Name: Steven Salamon Title: President Rosalind Master Fund L.P. By: Name: Mike McDonald Title:
February 16, 2024	EX-10.1	MULTI-DRAW SENIOR SECURED SUPER-PRIORITY PRIMING DEBTOR-IN-POSSESSION CREDIT AGREEMENT AND GUARANTY dated as of February 14, 2024 by and among SIENTRA, INC., as the Borrower, and as Debtor and Debtor-in-Possession under the Chapter 11 Bankruptcy Code Exhibit 10.1 EXECUTION VERSION MULTI-DRAW SENIOR SECURED SUPER-PRIORITY PRIMING DEBTOR-IN-POSSESSION CREDIT AGREEMENT AND GUARANTY dated as of February 14, 2024 by and among SIENTRA, INC., as the Borrower, and as Debtor and Debtor-in-Possession under the Chapter 11 Bankruptcy Code, the other Loan Parties party hereto from time to time, the Lenders party hereto from time to time, and DEERFIELD PART
February 16, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES ACT OF 1934 Date of Report (Date of earliest event reported): February 13, 2024 SIENTRA, INC. (Exact nam UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES ACT OF 1934 Date of Report (Date of earliest event reported): February 13, 2024 SIENTRA, INC. (Exact name of registrants as specified in its charters) Delaware 001-36709 20-5551000 (State or other jurisdiction of incorporation or organization) (Commissio
February 13, 2024	EX-99.1	Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process Company secures $22.5 million of new money in debtor-in-possession financing from existing lenders to support ongoing operations during the sale process Exhibit 99.1 Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process Company secures $22.5 million of new money in debtor-in-possession financing from existing lenders to support ongoing operations during the sale process IRVINE, Calif., Feb. 13, 2024 - Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company developing and commercializ
February 13, 2024	EX-10.1	MULTI-DRAW SENIOR SECURED SUPER-PRIORITY PRIMING DEBTOR-IN-POSSESSION CREDIT AGREEMENT AND GUARANTY dated as of February [ ], 2024 by and among SIENTRA, INC., as the Borrower, and as Debtor and Debtor-in-Possession under the Chapter 11 Bankruptcy Cod Exhibit 10.1 MULTI-DRAW SENIOR SECURED SUPER-PRIORITY PRIMING DEBTOR-IN-POSSESSION CREDIT AGREEMENT AND GUARANTY dated as of February [ ], 2024 by and among SIENTRA, INC., as the Borrower, and as Debtor and Debtor-in-Possession under the Chapter 11 Bankruptcy Code, the other Loan Parties party hereto from time to time, the Lenders party hereto from time to time, and DEERFIELD PARTNERS, L.P., as ag
February 13, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Other Events, Bankruptcy or Receivership UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES ACT OF 1934 Date of Report (Date of earliest event reported): February 12, 2024 SIENTRA, INC. (Exact name of registrants as specified in its charters) Delaware 001-36709 20-5551000 (State or other jurisdiction of incorporation or organization) (Commissio
February 6, 2024	SC 13G	US82621J2042 / Sientra, Inc. / WELLS FARGO & COMPANY/MN Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) SIENTRA INC (Name of Issuer) Common Stock (Title of Class of Securities) 82621J204 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is f
January 29, 2024	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES ACT OF 1934 Date of Report (Date of earliest event reported): January 28, 2024 SIENTRA, INC. (Exact name of registrants as specified in its charters) Delaware 001-36709 20-5551000 (State or other jurisdiction of incorporation or organization) (Commission
January 29, 2024	EX-10.1	AMENDMENT NO. 2 TO TEMPORARY WAIVER AND EXCHANGE AGREEMENT AND TEMPORARY AMENDMENT TO FACILITY AGREEMENT Exhibit 10.1 AMENDMENT NO. 2 TO TEMPORARY WAIVER AND EXCHANGE AGREEMENT AND TEMPORARY AMENDMENT TO FACILITY AGREEMENT This AMENDMENT NO. 2 TO TEMPORARY WAIVER AND EXCHANGE AGREEMENT AND TEMPORARY AMENDMENT TO FACILITY AGREEMENT (this “Agreement”), dated as of January 28, 2024, is by and among Sientra, Inc., a Delaware corporation (the “Borrower”), the other Loan Parties (as defined in the Facility
January 16, 2024	EX-10.1	AMENDMENT NO. 1 TO TEMPORARY WAIVER AND EXCHANGE AGREEMENT AND TEMPORARY AMENDMENT TO FACILITY AGREEMENT Exhibit 10.1 AMENDMENT NO. 1 TO TEMPORARY WAIVER AND EXCHANGE AGREEMENT AND TEMPORARY AMENDMENT TO FACILITY AGREEMENT This AMENDMENT NO. 1 TO TEMPORARY WAIVER AND EXCHANGE AGREEMENT AND TEMPORARY AMENDMENT TO FACILITY AGREEMENT (this “Agreement”), dated as of January 15, 2024, is by and among Sientra, Inc., a Delaware corporation (the “Borrower”), the other Loan Parties (as defined in the Facility
January 16, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES ACT OF 1934 Date of Report (Date of earliest event reported): January 15, 2024 SIENTRA, INC. (Exact name UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES ACT OF 1934 Date of Report (Date of earliest event reported): January 15, 2024 SIENTRA, INC. (Exact name of registrant as specified in its charter) Delaware 001-36709 20-5551000 (State or other jurisdiction of incorporation (Commission File Number) (I.R.
December 20, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES ACT OF 1934 Date of Report (Date of earliest event reported): December 14, 2023 SIENTRA, INC. (Exact nam UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES ACT OF 1934 Date of Report (Date of earliest event reported): December 14, 2023 SIENTRA, INC. (Exact name of registrant as specified in its charter) Delaware 001-36709 20-5551000 (State or other jurisdiction of incorporation) (Commission File Number) (I.
November 13, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36709 SIENT
November 9, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 09, 2023 SIENTRA, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-36709 20-5551000 (State or Other Jurisdiction of Incorporation) (Commission File Nu
November 9, 2023	EX-99.1	Sientra Reports THIRD Quarter FINANCIAL and operational Results Exhibit 99.1 Sientra Reports THIRD Quarter FINANCIAL and operational Results IRVINE, Calif., November 9, 2023 (GLOBE NEWSWIRE) - Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company developing the safest and most innovative solutions for the best aesthetic outcomes, today announced its financial results for the third quarter that ended September 30, 2023. Third
October 31, 2023	EX-99.1	Sientra Reports Preliminary Unaudited Third Quarter 2023 Financial Results and Provides Update on Outlook Exhibit 99.1 Sientra Reports Preliminary Unaudited Third Quarter 2023 Financial Results and Provides Update on Outlook IRVINE, Calif., October. 30, 2023 (GLOBE NEWSWIRE) - Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company delivering the safest and most innovative solutions for the best outcomes, today announced preliminary unaudited financial results for the
October 31, 2023	EX-4.1	Form of Pre-Funded Warrant Exhibit 4.1 PRE-FUNDED WARRANT TO PURCHASE SHARES OF COMMON STOCK OF SIENTRA, INC. Original Issue Date: [] No. [] FOR VALUE RECEIVED, the undersigned, Sientra, Inc., a Delaware corporation (together with its successors and assigns, the “Company”), hereby certifies that Deerfield Partners, L.P. or any transferee, assignee or other subsequent holder hereof (the “Holder”) is entitled to subscribe for
October 31, 2023	EX-10.1	Temporary Waiver and Exchange Agreement, dated as of October 30, 2023, among Sientra, Inc., the other loan parties party thereto and Deerfield Partners, L.P. Exhibit 10.1 TEMPORARY WAIVER AND EXCHANGE AGREEMENT This TEMPORARY WAIVER AND EXCHANGE AGREEMENT (including the schedules, annexes and exhibits hereto, this “Agreement”), dated as of October 30, 2023 (the “Effective Date”), is by and among Sientra, Inc., a Delaware corporation (the “Borrower” or the “Company” as applicable), the other Loan Parties (as defined in the Facility Agreement (as defined
October 31, 2023	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES ACT OF 1934 Date of Report (Date of earliest event reported): October 30, 2023 SIENTRA, INC. (Exact name of registrant as specified in its charter) Delaware 001-36709 20-5551000 (State or other jurisdiction of incorporation (Commission File Number) (I.R.
August 11, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36709 SIENTRA, I
August 10, 2023	EX-99.1	Sientra Reports RECORD Second Quarter FINANCIAL and operational Results Revenue growth of 7.5% driven by continued market share gains in reconstruction and augmentation Best operational results in company history with 95% and 63% year-over-year impro Exhibit 99.1 Sientra Reports RECORD Second Quarter FINANCIAL and operational Results Revenue growth of 7.5% driven by continued market share gains in reconstruction and augmentation Best operational results in company history with 95% and 63% year-over-year improvement in operating cash flow and adjusted EBITDA respectively. Continued success in advancing products through the FDA regulatory proces
August 10, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2023 SIENTRA, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-36709 20-5551000 (State or Other Jurisdiction of Incorporation) (Commission File Numb
June 22, 2023	S-8	As filed with the Securities and Exchange Commission on June 22, 2023 S-8 As filed with the Securities and Exchange Commission on June 22, 2023 Registration No.
June 22, 2023	EX-FILING FEES	Filing Fee Table. Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Sientra, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, $0.01 par value per
June 20, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 15, 2023 SIENTRA, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-36709 20-5551000 (State or Other Jurisdiction of Incorporation) (Commission File Number
May 15, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36709 SIENTRA,
May 11, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 11, 2023 SIENTRA, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-36709 20-5551000 (State or Other Jurisdiction of Incorporation) (Commission File Number)
May 11, 2023	EX-99.1	SIENTRA REPORTS RECORD FIRST QUARTER 2023 OPERATIONAL RESULTS Exhibit 99.1 SIENTRA REPORTS RECORD FIRST QUARTER 2023 OPERATIONAL RESULTS 05/11/2023 Eleventh consecutive quarter of year-over-year growth, fueled by market outperformance in reconstruction Continued improvement in non-GAAP OPEX, adjusted EBITDA, and free cash flow performance demonstrating clear pathway to profitability Doubled total addressable market in the United States with commercial launch
May 1, 2023	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
May 1, 2023	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
April 18, 2023	EX-FILING FEES	Filing Fee Table. Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Sientra, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, $0.01 par value per
April 18, 2023	S-8	Power of Attorney (included on signature pages hereto) As filed with the Securities and Exchange Commission on April 17, 2023 Registration No.
April 18, 2023	EX-21	List of significant subsidiaries of the registrant. Exhibit 21.1 Subsidiaries Subsidiary Jurisdiction miraDry Holdings, Inc. Delaware miraDry, Inc. Delaware miraDry International, Inc. Delaware Miramar Labs HK Ltd. Hong Kong miraDry International Sweden AB Sweden
April 18, 2023	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K 3black UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-36709 SIENTRA, INC. (Exact Name of Registrant a
April 18, 2023	EX-4	Description of the Company’s securities Exhibit 4.3 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Sientra, Inc. (“Sientra,” “we,” “our,” or “us”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: our common stock. DESCRIPTION OF CAPITAL STOCK The following summary of the terms of our capital stock is based upon
March 31, 2023	NT 10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 001-36709 CUSIP NUMBER: 82621J105 (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Period Ended: Read Instruction (on back page) Before Preparing Form.
March 30, 2023	EX-99	SIENTRA REPORTS RECORD FOURTH QUARTER AND FULL YEAR REVENUES AND EXPANDS TOTAL ADDRESSABLE MARKET WITH NEW PRODUCT LAUNCHES Exhibit 99.1 SIENTRA REPORTS RECORD FOURTH QUARTER AND FULL YEAR REVENUES AND EXPANDS TOTAL ADDRESSABLE MARKET WITH NEW PRODUCT LAUNCHES 03/30/2023 Continued 2+ year trend of consecutive record quarterly growth; fastest growing brand in the US breast market Disciplined cash management and enhanced operating leverage for 40% improvement in free cash flow results Significantly increased total addres
March 30, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 30, 2023 SIENTRA, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-36709 20-5551000 (State or Other Jurisdiction of Incorporation) (Commission File Numbe
February 15, 2023	SC 13G	SIEN / Sientra Inc / Rosalind Advisors, Inc. - SIENTRA SC13 G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Sientra, Inc. (Name of Issuer) Common Shares (Title of Class of Securities) 82621J204 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ¨ Rule 1
February 15, 2023	EX-99.A BD-DIR-RESOL	Joint Filing Agreement EX-99.A BD-DIR-RESOL 2 exa.htm EXHIBIT JOINT FILING Exhibit A Joint Filing Agreement The undersigned hereby agree that this Statement on Schedule 13G with respect to the beneficial ownership of shares of Common Stock of Sientra, Inc. is filed jointly, on behalf of each of them. Rosalind Advisors, Inc. By: Name: Steven Salamon Title: President Rosalind Master Fund L.P. By: Name: Mike McDonald Title
February 10, 2023	SC 13G/A	SIEN / Sientra Inc / Senvest Management, LLC - SIENTRA, INC. Passive Investment SC 13G/A 1 p23-0630sc13ga.htm SIENTRA, INC. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Sientra, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 82621J204 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate
January 19, 2023	EX-3.1	Certificate of Amendment, filed January 19, 2023 EX-3.1 Exhibit 3.1 CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SIENTRA, INC. a Delaware corporation Sientra, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “DGCL”), hereby certifies as follows: 1. The name of the Corporation is Sientra, Inc. The date of filing o
January 19, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 19, 2022 SIENTRA, INC. ( UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 19, 2022 SIENTRA, INC. (Exact name of registrant as specified in its charter) Commission File Number: 001-36709 Delaware 20-5551000 (State or other jurisdiction of incorporat
December 20, 2022	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 19, 2022 SIENTRA, INC. (Exact name of registrant as specified in its charter) Commission File Number: 001-36709 Delaware 20-5551000 (State or other jurisdiction of incorporat
December 20, 2022	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin
December 20, 2022	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
December 16, 2022	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) DEFA14A 1 d363321ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as
December 12, 2022	CORRESP	VIA EDGAR VIA EDGAR December 12, 2022 United States Securities and Exchange Commission Division of Corporation Finance Office of Trade & Services 100 F Street, N.
December 6, 2022	EX-FILING FEES	Filing Fee Table EX-FILING FEES Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Sientra, Inc.
December 6, 2022	S-3	As filed with the Securities and Exchange Commission on December 5, 2022 S-3 1 d380201ds3.htm S-3 Table of Contents As filed with the Securities and Exchange Commission on December 5, 2022 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Sientra, Inc. (Exact name of registrant as specified in its charter) Delaware 20-5551000 (State or other jurisdiction of inco
November 29, 2022	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
November 17, 2022	PRE 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14
November 15, 2022	SC 13D	SIEN / Sientra Inc / PESSIN NORMAN H - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* SIENTRA, INC. (Name of Issuer) Common stock, par value $0.01 per share (Title of Class of Securities) 82621J105 (CUSIP Number) Norman H. Pessin Brian L. Pessin 400 E 51st St PH 31 New York, New York 10022 (917) 887-1982 (Name, Address and Telephone Number
November 14, 2022	EX-10.4	Amendment to Amended and Restated Facility Agreement, dated October 20, 2022, by and between Sientra, Inc. and Deerfield Partners, L.P. October 20, 2022 Sientra, Inc. 420 South Fairview Avenue, Suite 200 Santa Barbara, CA 93117 Re: Amendment to Convertible Notes and Facility Agreement Ladies and Gentlemen: Reference is hereby made to that certain Amended and Restated Facility Agreement, dated as of October 12, 2022 (as the same may be further amended, restated, supplemented or otherwise modified from time to time, the ?Facility Ag
November 14, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36709 SIENT
November 10, 2022	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2022 SIENTRA, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-36709 20-5551000 (State or Other Jurisdiction of Incorporation) (Commission File Nu
November 10, 2022	EX-99.1	Sientra Reports Record Third Quarter 2022 Financial Results Exhibit 99.1 Sientra Reports Record Third Quarter 2022 Financial Results Santa Barbara, CA ? November 10, 2022 ? Sientra, Inc. (NASDAQ: SIEN) (?Sientra? or the ?Company?), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced its financial results for the third quarter that ended September 30, 2022. Q3 2022 Financial and Business Highlight
October 27, 2022	EX-99.2	Sientra Announces Pricing of $13.2 Million Public Offering EX-99.2 Exhibit 99.2 Sientra Announces Pricing of $13.2 Million Public Offering SANTA BARBARA, Calif., October 21, 2022 (GLOBE NEWSWIRE) — Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced the pricing of its previously announced underwritten public offering of 34,782,600 shares
October 27, 2022	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 21, 2022 SIENTRA, INC. (E UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 21, 2022 SIENTRA, INC. (Exact name of registrant as specified in its charter) Commission File Number: 001-36709 Delaware 20-5551000 (State or other jurisdiction of incorporati
October 27, 2022	EX-4.2	Form of Pre-Funded Warrant EX-4.2 Exhibit 4.2 EXHIBIT C PREFUNDED COMMON STOCK PURCHASE WARRANT SIENTRA, INC. Warrant Shares: Initial Exercise Date: October , 2022 THIS PREFUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
October 27, 2022	EX-4.1	Form of Warrant EX-4.1 Exhibit 4.1 EXHIBIT B COMMON STOCK PURCHASE WARRANT SIENTRA, INC. Warrant Shares: Initial Exercise Date: October , 2022 THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (th
October 27, 2022	EX-99.1	SIENTRA ANNOUNCES PROPOSED PUBLIC OFFERING EX-99.1 Exhibit 99.1 SIENTRA ANNOUNCES PROPOSED PUBLIC OFFERING 10/18/2022 SANTA BARBARA, Calif., October 18, 2022 (GLOBE NEWSWIRE) — Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced that it intends to offer and sell in an underwritten public offering, subject to market and ot
October 27, 2022	EX-1.1	Underwriting Agreement, dated October 21, 2022, by and between Sientra, Inc. and Craig-Hallum Capital Group LLC EX-1.1 Exhibit 1.1 12,567,610 Shares of Common Stock, 22,214,990 Prefunded Warrants (to purchase 22,214,990 shares of Common Stock) and 34,782,600 Common Warrants (to purchase 34,782,600 shares of Common Stock) SIENTRA, INC. UNDERWRITING AGREEMENT October 21, 2022 Craig-Hallum Capital Group LLC As representative of the Underwriters named in Schedule I hereto 222 South Ninth Street, Suite 350 Minne
October 24, 2022	424B5	12,567,610 Shares of Common Stock Pre-Funded Warrants to Purchase up to 22,214,990 Shares of Common Stock Warrants to Purchase up to 34,782,600 Shares of Common Stock Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-264888 PROSPECTUS SUPPLEMENT (To prospectus dated May 27, 2022) 12,567,610 Shares of Common Stock Pre-Funded Warrants to Purchase up to 22,214,990 Shares of Common Stock Warrants to Purchase up to 34,782,600 Shares of Common Stock We are offering up to 12,567,610 shares of our common stock, par value $0.01 per share, and warra
October 20, 2022	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 20, 2022 SIENTRA, INC. (E UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 20, 2022 SIENTRA, INC. (Exact name of registrant as specified in its charter) Commission File Number: 001-36709 Delaware 20-5551000 (State or other jurisdiction of incorporati
October 18, 2022	424B5	SUBJECT TO COMPLETION, DATED OCTOBER 18, 2022 424B5 1 d391572d424b5.htm 424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-264888 The information in this preliminary prospectus supplement is not complete and may be changed. Neither this preliminary prospectus supplement nor the accompanying prospectus is an offer to sell these securities, and we are not soliciting an offer to buy these securities, in any jurisdictio
October 17, 2022	424B3	SIENTRA, INC. 14,634,147 Shares Common Stock Filed Pursuant to Rule 424(b)(3) Registration No. 333-237636 PROSPECTUS SUPPLEMENT (to Prospectus dated May 7, 2020) SIENTRA, INC. 14,634,147 Shares Common Stock This prospectus supplement updates, amends and supplements the selling stockholders table and related footnotes contained in the prospectus dated May 7, 2020 (the ?Prospectus?), which Prospectus forms a part of the Registration Statement
October 12, 2022	EX-4.4	Form of Exchange Warrant Exhibit 4.4 Execution Version PRE-FUNDED WARRANT TO PURCHASE SHARES OF COMMON STOCK OF SIENTRA, INC. Original Issue Date: October 12, 2022 No. W-1 FOR VALUE RECEIVED, the undersigned, Sientra, Inc., a Delaware corporation (together with its successors and assigns, the ?Company?), hereby certifies that Deerfield Partners, L.P. or any transferee, assignee or other subsequent holder hereof (the ?Hold
October 12, 2022	EX-10.3	Amended and Restated Registration Rights Agreement, by and between Sientra, Inc. and Deerfield Partners, L.P. Exhibit 10.3 AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT This AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this ?Agreement?), dated as of October 12, 2022, is entered into by and among Sientra, Inc., a Delaware corporation (the ?Company?), and Deerfield Partners, L.P. (the ?Lender?). Capitalized terms used and not otherwise defined herein have the meanings given to them in the Facili
October 12, 2022	EX-4.3	Form of Warrant Exhibit 4.3 Execution Version THE OFFER AND SALE OF THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), OR ANY STATE SECURITIES LAW. THE SECURITIES MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT, EXCEPT PURSUANT TO AN EXEMP
October 12, 2022	EX-99.1	SIENTRA ANNOUNCES PRELIMINARY UNAUDITED THIRD QUARTER FINANCIAL RESULTS AND SIGNING OF SENIOR SECURED LOAN FACILITIES WITH DEERFIELD MANAGEMENT Anticipates total third quarter net sales of $21.5-$22.5 million, up 10-15% compared to the prior year per Exhibit 99.1 SIENTRA ANNOUNCES PRELIMINARY UNAUDITED THIRD QUARTER FINANCIAL RESULTS AND SIGNING OF SENIOR SECURED LOAN FACILITIES WITH DEERFIELD MANAGEMENT Anticipates total third quarter net sales of $21.5-$22.5 million, up 10-15% compared to the prior year period Restructured balance sheet with senior secured convertible debt with Deerfield Management SANTA BARBARA, Calif., October 12, 2022 (GL
October 12, 2022	EX-4.2	Form of 2022 Note Exhibit 4.2 Execution Version THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER SAID ACT, OR PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER SAID ACT INCLUDING
October 12, 2022	EX-4.1	Form of Original Note Exhibit 4.1 Execution Version THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER SAID ACT, OR PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER SAID ACT INCLUDING
October 12, 2022	EX-10.2	Exchange Agreement, dated October 12, 2022, by and between Sientra, Inc. and Deerfield Partners, L.P. Exhibit 10.2 Execution Version EXCHANGE AGREEMENT This EXCHANGE AGREEMENT (including the schedules, annexes and exhibits hereto, this ?Agreement?), dated as of October 12, 2022 (the ?Effective Date?), is by and between Sientra, Inc., a Delaware corporation (the ?Borrower?), and Deerfield Partners, L.P., in its capacity as Agent for itself as a lender and as lender (the ?Lender?). Capitalized terms
October 12, 2022	EX-10.1	Amended and Restated Facility Agreement, dated October 12, 2022, by and between Sientra, Inc. and Deerfield Partners, L.P. Exhibit 10.1 Execution Version AMENDED AND RESTATED FACILITY AGREEMENT dated as of October 12, 2022 by and among SIENTRA, INC., as the Borrower, the other Loan Parties party hereto from time to time, the Lenders and DEERFIELD PARTNERS, L.P., as agent for itself and the Lenders Table of Contents Article 1 DEFINITIONS 1 Section 1.1 General Definitions 1 Section 1.2 Interpretation 29 Section 1.3 Busi
October 12, 2022	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 12, 2022 SIENTRA, INC. (Exact name of registrant as specified in its charter) Commission File Number: 001-36709 Delaware 20-5551000 (State or other jurisdiction of incorporati
October 11, 2022	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 11, 2022 SIENTRA, INC. (Exact name of registrant as specified in its charter) Delaware 001-36709 20-5551000 (State or other jurisdiction of incorporation) (Commission File Num
October 5, 2022	8-K	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 29, 2022 SIENTRA, INC. (Exact name of registrant as specified in its charter) Delaware 001-36709 20-5551000 (State or other jurisdiction of incorporation) (Commission File N
August 11, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2022 SIENTRA, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-36709 20-5551000 (State or Other Jurisdiction of Incorporation) (Commission File Numb
August 11, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36709 SIENTRA, I
August 11, 2022	EX-99.1	Sientra Reports Second Quarter Revenue Growth Driven By Increased Acceleration in Reconstruction Channel Exhibit 99.1 Sientra Reports Second Quarter Revenue Growth Driven By Increased Acceleration in Reconstruction Channel Santa Barbara, CA ? August 11, 2022 ? Sientra, Inc. (NASDAQ: SIEN) (?Sientra? or the ?Company?), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced its financial results for the second quarter that ended June 30, 2022. Q
June 15, 2022	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 10, 2022 SIENTRA, INC. (Exact name of registrant as specified in its charter) Commission File Number: 001-36709 Delaware 20-5551000 (State or other jurisdiction of incorporation)
June 15, 2022	EX-10.1	Multi-Tenant Office Lease (FSG), dated June 10, 2022, by and between Sientra, Inc. and LBA IV-PPI, LLC. Exhibit 10.1 MULTI-TENANT OFFICE LEASE (FSG) PARK PLACE I Irvine, California LANDLORD: LBA IV-PPI, LLC, a Delaware limited liability company TENANT: SIENTRA, INC., a Delaware corporation TABLE OF CONTENTS ARTICLE 1?LEASE SUMMARY AND PROJECT SPECIFIC PROVISIONS 1 ARTICLE 2?LEASE 14 ARTICLE 3?PREMISES 14 ARTICLE 4?TERM AND POSSESSION 15 ARTICLE 5?RENT 15 ARTICLE 6?LETTER OF CREDIT 16 ARTICLE 7?OPERA
June 14, 2022	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 9, 2022 SIENTRA, INC. (Exact name of registrant as specified in its charter) Delaware 001-36709 20-5551000 (State or other jurisdiction of incorporation) (Commission File Number)
May 25, 2022	CORRESP	May 25, 2022 CORRESP 1 filename1.htm May 25, 2022 Via EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549-4561 Attn: Ms. Gama Re: Sientra, Inc. Registration Statement on Form S-3 File No. 333-264888 Ladies and Gentlemen: Pursuant to Rule 461 of the Securities Act of 1933, as amended, Sientra, Inc. (the “Company”) hereby requests that the Securities and
May 12, 2022	EX-10.1	Third Amendment to Second Amended and Restated Credit and Security Agreement (Term Loan), dated March 30, 2022, between the Company, Mist Holdings, Inc., Mist, Inc., Mist International, Inc, MidCap Financial Trust, and the other lenders party thereto. CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH ?[***]?.
May 12, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36709 SIENTRA,
May 12, 2022	EX-99.1	Sientra Reports Seventh Consecutive Quarter of Record Growth for First Quarter 2022 Record Growth Driven by Continued Expansion of Augmentation and Reconstruction Accounts Accelerated Gross Margin Improvement Through Execution of Commercial and Opera Exhibit 99.1 Sientra Reports Seventh Consecutive Quarter of Record Growth for First Quarter 2022 Record Growth Driven by Continued Expansion of Augmentation and Reconstruction Accounts Accelerated Gross Margin Improvement Through Execution of Commercial and Operational Plans Santa Barbara, CA ? May 12, 2022 ? Sientra, Inc. (NASDAQ: SIEN) (?Sientra? or the ?Company?), a medical aesthetics company f
May 12, 2022	EX-10.2	Sixth Amendment to Amended and Restated Credit and Security Agreement (Revolving Loan), dated March 30, 2022, between the Company, Mist Holdings, Inc., Mist, Inc., Mist International, Inc, MidCap Financial Trust, and the other lenders party thereto (incorporated by reference to Exhibit 10.5 to the Company’s Form 10-Q filed on August 10, 2021). CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH ?[***]?.
May 12, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 12, 2022 SIENTRA, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-36709 20-5551000 (State or Other Jurisdiction of Incorporation) (Commission File Number)
May 12, 2022	EX-4.5	Form of Subordinated Indenture Exhibit 4.5 .SIENTRA, INC. ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20 SUBORDINATED DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS 1 Section 1.01 Definitions of Terms 1 ARTICLE 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 3 Section 2.01 Designation and Terms of Securities 3 Section 2.02 Form of Securities and Trustee?s Certificate 4 Sec
May 12, 2022	EX-FILING FEES	Filing Fee Table EX-FILING FEES 6 d335905dexfilingfees.htm EX-FILING FEES Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Sientra, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit (2) Maximum Aggre
May 12, 2022	S-3	As filed with the Securities and Exchange Commission on May 12, 2022 Table of Contents As filed with the Securities and Exchange Commission on May 12, 2022 Registration No.
May 12, 2022	EX-4.4	Form of Senior Indenture Exhibit 4.4 SIENTRA, INC. ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20 SENIOR DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 1 Section 1.1 Definitions of Terms 1 ARTICLE II ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 3 Section 2.1 Designation and Terms of Securities 3 Section 2.2 Form of Securities and Trustee?s Certificate 4 Section 2.3
May 4, 2022	SC 13D/A	SIEN / Sientra Inc / Clarus Lifesciences I, L.P. - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Sientra, Inc. (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 82621J105 (CUSIP Number) Robert Liptak Clarus Ventures, LLC 101 Main Street, Suite 1210 Cambridge, MA 02142 (617) 949-2200 (Name, Address and T
April 29, 2022	DEF 14A	definitive proxy statement DEF 14A 1 d251921ddef14a.htm DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Com
April 29, 2022	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin
April 1, 2022	EX-FILING FEES	Calculation of Filing Fee Table. Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Sientra, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, $0.01 par value per
April 1, 2022	S-8	As filed with the Securities and Exchange Commission on March 31, 2022 As filed with the Securities and Exchange Commission on March 31, 2022 Registration No.
March 31, 2022	EX-21.1	List of significant subsidiaries of the registrant. Exhibit 21.1 Subsidiaries Subsidiary Jurisdiction miraDry Holdings, Inc. Delaware miraDry, Inc. Delaware miraDry International, Inc. Delaware Miramar Labs HK Ltd. Hong Kong miraDry International Sweden AB Sweden
March 31, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-36709 SIENTRA, INC. (Exact Name of Registrant as Speci
March 31, 2022	EX-4.3	Description of Securities (incorporated by reference to our Annual Report on Form 10-K filed with the Commission on March 31, 2022). Exhibit 4.3 DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Sientra, Inc. (?Sientra,? ?we,? ?our,? or ?us?) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: our common stock. DESCRIPTION OF CAPITAL STOCK The following summary of the terms of our capital stock is based upon
March 25, 2022	EX-99.1	Sientra Receives Regulatory Approval to Market Breast Implants in Canada Health Canada approval continues Sientra’s international expansion and growth acceleration EX-99.1 Exhibit 99.1 Sientra Receives Regulatory Approval to Market Breast Implants in Canada Health Canada approval continues Sientra’s international expansion and growth acceleration Santa Barbara, CA – March 24, 2022 – Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, announced today that i
March 25, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 23, 2022 SIENTRA, INC. (Exact name of registrant as specified in its charter) Delaware 001-36709 20-5551000 (State or other jurisdiction of incorporation) (Commission File Numbe
March 23, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 23, 2022 SIENTRA, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-36709 20-5551000 (State or Other Jurisdiction of Incorporation) (Commission File Numbe
March 23, 2022	EX-99.1	Sientra Reports Record Plastic Surgery Revenue for Both Fourth Quarter and Full Year 2021 Sixth Consecutive Quarter of Record Growth Doubled Augmentation and Reconstruction Market Share Since 2019 Broadened Market Opportunity with Addition of Novel, Exhibit 99.1 Sientra Reports Record Plastic Surgery Revenue for Both Fourth Quarter and Full Year 2021 Sixth Consecutive Quarter of Record Growth Doubled Augmentation and Reconstruction Market Share Since 2019 Broadened Market Opportunity with Addition of Novel, FDA-Cleared Fat Grafting Technology Santa Barbara, CA ? March 23, 2022 ? Sientra, Inc. (NASDAQ: SIEN) (?Sientra? or the ?Company?), a med
February 11, 2022	SC 13G	SIEN / Sientra Inc / MORGAN STANLEY - MS INITIAL Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* Sientra, Inc. - (Name of Issuer) Common Stock - (Title of Class of Securities) 82621J105 - (CUSIP Number) December 31, 2021 - (Date Of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sch
February 11, 2022	SC 13G	SIEN / Sientra Inc / Senvest Management, LLC - SIENTRA, INC. Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Sientra, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 82621J105 (CUSIP Number) February 9, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which thi
February 10, 2022	SC 13G/A	SIEN / Sientra Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: Sientra Inc. Title of Class of Securities: Common Stock CUSIP Number: 82621J105 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 1
January 10, 2022	EX-99.1	Sientra Reports Record Preliminary Unaudited Fourth Quarter and Full Year 2021 Revenues Exhibit 99.1 Sientra Reports Record Preliminary Unaudited Fourth Quarter and Full Year 2021 Revenues ? Estimates highest ever Breast Products yearly revenue of $80-$81 million representing 46%-47% full year growth ? Results driven by continued strong demand for Sientra Breast Products and commercial execution Santa Barbara, CA ? January 10, 2021 ? Sientra, Inc. (NASDAQ: SIEN) (?Sientra? or the ?Co
January 10, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2022 SIENTRA, INC. (Exact name of registrant as specified in its charter) Commission File Number: 001-36709 Delaware 20-5551000 (State or other jurisdiction of incorporati
January 5, 2022	EX-10.3	Limited Consent and Fifth Amendment to Amended and Restated Credit and Security Agreement (Revolving Loan), dated December 31, 2021, by and among Sientra, Inc., certain of its wholly owned subsidiaries, the lenders party thereto and MidCap Financial Trust. Exhibit 10.3 Execution Version LIMITED CONSENT AND FIFTH AMENDMENT TO AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (REVOLVING LOAN) This LIMITED CONSENT AND FIFTH AMENDMENT TO AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (REVOLVING LOAN) (this ?Agreement?) is made as December 31, 2021, by and among SIENTRA, INC., a Delaware corporation, MIST HOLDINGS, INC., a Delaware corporation (form
January 5, 2022	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 31, 2021 SIENTRA, INC. (Exact name of registrant as specified in its charter) Commission File Number: 001-36709 Delaware 20-5551000 (State or other jurisdiction of incorporat
January 5, 2022	EX-10.4	Amendment No. 3 to the Facility Agreement, dated December 31, 2021, by and between Sientra, Inc. and Deerfield Partners, L.P. Exhibit 10.4 EXECUTION VERSION AMENDMENT NO. 3 TO FACILITY AGREEMENT This AMENDMENT NO. 3 TO FACILITY AGREEMENT, dated as of December 31, 2021 (this ?Agreement?), is entered into among SIENTRA, INC., a Delaware corporation (the ?Borrower?), each of the Loan Parties party hereto, the Lenders party hereto constituting the Required Lenders, and DEERFIELD PARTNERS, L.P., as Agent for itself and the Le
January 5, 2022	EX-10.2	Limited Consent and Second Amendment to Second Amended and Restated Credit and Security Agreement (Term Loan), dated December 31, 2021, by and among Sientra, Inc., certain of its wholly owned subsidiaries, the lenders party thereto and MidCap Financial Trust. Exhibit 10.2 Execution Version LIMITED CONSENT AND SECOND AMENDMENT TO SECOND AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (TERM LOAN) This LIMITED CONSENT AND SECOND AMENDMENT TO SECOND AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (TERM LOAN) (this ?Agreement?) is made as December 31, 2021, by and among SIENTRA, INC., a Delaware corporation, MIST HOLDINGS, INC., a Delaware corporation
January 5, 2022	EX-10.1	Asset Purchase Agreement to Facility Agreement, dated December 31, 2021, by and between Sientra, Inc. and AuraGen Aesthetics LLC. Exhibit 10.1 Portions of this Exhibit have been redacted because they (i) are not material and would be competitively harmful if publicly disclosed or (ii) are personal and confidential. Information that was omitted has been noted in this document with a placeholder identified by the mark ?[***]? Execution Copy ASSET PURCHASE AGREEMENT This ASSET PURCHASE AGREEMENT (this ?Agreement?), dated as of
November 12, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36709 SIENT
November 10, 2021	EX-99.1	Sientra Reports Record Third Quarter 2021 Revenue for Continuing Operations Revenue growth of 28% Year Over Year Exhibit 99.1 Sientra Reports Record Third Quarter 2021 Revenue for Continuing Operations Revenue growth of 28% Year Over Year Santa Barbara, CA ? November 10, 2021 ? Sientra, Inc. (NASDAQ: SIEN) (?Sientra? or the ?Company?), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced its financial results for the third quarter ended September 30
November 10, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 10, 2021 SIENTRA, INC.
October 4, 2021	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 28, 2021 SIENTRA, INC. (Exact name of registrant as specified in its charter) Commission File Number: 001-36709 Delaware 20-5551000 (State or other jurisdiction of incorpora
October 4, 2021	EX-10.1	First Amendment to Facility Agreement, dated September 28, 2021, by and between Sientra, Inc. and Deerfield Partners, L.P. Exhibit 10.1 Execution Version FIRST AMENDMENT TO FACILITY AGREEMENT FIRST AMENDMENT TO FACILITY AGREEMENT (this ?Amendment?) dated as of September 28, 2021, by and between SIENTRA, INC., a Delaware corporation (the ?Borrower?), and DEERFIELD PARTNERS, L.P., as Agent and Lender (the ?Agent?). RECITALS: A. The Borrower, the other Loan Parties (as defined in the Facility Agreement) party thereto fro
September 8, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 2, 2021 SIENTRA, INC. (Exact name of registrant as specified in its charter) Delaware 001-36709 20-5551000 (State or other jurisdiction of incorporation) (Commission File Nu
August 10, 2021	EX-10.2	Asset Purchase Agreement, dated May 11, 2021, between the Company, miraDry Acquisition Company, Inc., and, solely for purposes of Section 8.14 of the Purchase Agreement, 1315 Capital II, LP. Exhibit 10.2 ASSET PURCHASE AGREEMENT among MIRADRY, INC., MIRADRY HOLDINGS, INC., MIRADRY INTERNATIONAL, INC. MIRADRY ACQUISITION COMPANY, INC. and 1315 CAPITAL, LLC (solely for purposes of Section 8.14) dated as of May 11, 2021 ACTIVE 55877614v16 TABLE OF CONTENTS ARTICLE I Purchase and Sale 1 Section 1.01 Purchase and Sale of Purchased Assets 1 Section 1.02 Excluded Assets 3 Section 1.03 Assume
August 10, 2021	EX-10.3	Sublease Agreement, dated May 17, 2021, between miraDry, Inc. and MiraDry Acquisition Company, Inc. Exhibit 10.3 SUBLEASE AGREEMENT THIS SUBLEASE AGREEMENT dated as of May 17, 2021 (this ?Sublease?), is made and entered into by and between MIRADRY, INC., a Delaware corporation (?Sublandlord?), and MIRADRY ACQUISITION COMPANY, INC., a Delaware corporation (?Subtenant?), with reference to the following facts and understandings: WHEREAS, IPX Walsh Bowers Investors, L.P., a Delaware limited liabilit
August 10, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 10, 2021 SIENTRA, INC.
August 10, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36709 SIENTRA, I
August 10, 2021	EX-10.4	First Amendment to Second Amended and Restated Credit and Security Agreement (term loan), dated July 14, 2021, between the Company, Mist Holdings, Inc., Mist, Inc., Mist International, Inc, MidCap Financial Trust, and the other lenders party thereto. Exhibit 10.4 FIRST AMENDMENT TO SECOND AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (TERM LOAN) This FIRST AMENDMENT TO SECOND AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (TERM LOAN) (this ?Agreement?) is made as of July 14, 2021, by and among SIENTRA, INC., a Delaware corporation, MIST HOLDINGS, INC., a Delaware corporation (formerly known as Miramar Labs, Inc. and MiraDry Holdings,
August 10, 2021	EX-99.1	Sientra Reports Record Breast Products Revenue for Second Quarter 2021 Raises Revenue Guidance for Full Year 2021 Exhibit 99.1 Sientra Reports Record Breast Products Revenue for Second Quarter 2021 Raises Revenue Guidance for Full Year 2021 Santa Barbara, CA ? August 10, 2021 ? Sientra, Inc. (NASDAQ: SIEN) (?Sientra? or the ?Company?), a medical aesthetics company exclusively focused on plastic surgery, today announced its financial results for the second quarter ended June 30, 2021. Second Quarter 2021 Finan
August 10, 2021	EX-10.5	Fourth Amendment to Amended and Restated Credit and Security Agreement (Revolving Loan), dated July 14, 2021, between the Company, Mist Holdings, Inc., Mist, Inc., Mist International, Inc, MidCap Financial Trust, and the other lenders party thereto. Exhibit 10.5 FourTH AMENDMENT TO AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (REVOLVING LOAN) This FOURTH AMENDMENT TO AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (REVOLVING LOAN) (this ?Agreement?) is made as July 14, 2021, by and among SIENTRA, INC., a Delaware corporation, MIST HOLDINGS, INC., a Delaware corporation (formerly known as Miramar Labs, Inc. and MiraDry Holdings, Inc.)
July 22, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 16, 2021 SIENTRA, INC. (Exact name of registrant as specified in its charter) Delaware 001-36709 20-5551000 (State or other jurisdiction of incorporation) (Commission File Number
July 13, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 12, 2021 SIENTRA, INC. (Exact name of registrant as specified in its charter) Delaware 001-36709 20-5551000 (State or other jurisdiction of incorporation) (Commission File Number
July 13, 2021	EX-10.1	SIENTRA, INC. EMPLOYMENT AGREEMENT Andrew Schmidt Exhibit 10.1 SIENTRA, INC. EMPLOYMENT AGREEMENT Andrew Schmidt This Executive Employment Agreement (the ?Agreement?), made between Sientra, Inc., a Delaware company (the ?Company?), and Andrew Schmidt (?Executive?) (collectively, the ?Parties?), and shall be effective as of July 12, 2021 (the ?Effective Date?). WHEREAS, the Company desires to employ Executive pursuant to the terms, provisions and
June 16, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 10, 2021 SIENTRA, INC.
June 16, 2021	EX-99.2	Sientra Announces Closing of Previously Announced Sale of miraDry Business to 1315 Capital Exhibit 99.2 Sientra Announces Closing of Previously Announced Sale of miraDry Business to 1315 Capital Santa Barbara, CA ? June 11, 2021 ? Sientra, Inc. (NASDAQ: SIEN) (?Sientra? or the ?Company?), a medical aesthetics company uniquely focused on plastic surgeons, today announced it has closed the previously announced sale of its miraDry business to 1315 Capital, a healthcare growth equity firm i
June 16, 2021	EX-99.1	Sientra, Inc Unaudited Pro Forma Financial Statements Exhibit 99.1 Sientra, Inc Unaudited Pro Forma Financial Statements On June 10, 2021, Sientra, Inc., a Delaware corporation (?Sientra?), completed the previously announced sale of its miraDry business (the ?Sale?) to miraDry Acquisition Company, Inc., a Delaware corporation (?Buyer?), an entity affiliated with 1315 Capital II, LP. The Sale was made pursuant to the terms and conditions of the Asset
June 14, 2021	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 10, 2021 SIENTRA, INC. (Exact name of registrant as specified in its charter) Delaware 001-36709 20-5551000 (State or other jurisdiction of incorporation) (Commission File Number
May 11, 2021	EX-99.1	Sientra Reports Record First Quarter 2021 Financial Results Exhibit 99.1 Sientra Reports Record First Quarter 2021 Financial Results Santa Barbara, CA ? May 11, 2021 ? Sientra, Inc. (NASDAQ: SIEN) (?Sientra? or the ?Company?), a medical aesthetics company uniquely focused on plastic surgeons, today announced its financial results for the first quarter ended March 31, 2021. First Quarter 2021 Financial Highlights ? Q1 2021 total net sales of $23.2 million,
May 11, 2021	EX-99.1	Sientra Announces Sale of miraDry Business to 1315 Capital Transaction Enables Sharper Focus on Company’s Rapidly Growing Breast Product Business Exhibit 99.1 Sientra Announces Sale of miraDry Business to 1315 Capital Transaction Enables Sharper Focus on Company?s Rapidly Growing Breast Product Business Santa Barbara, CA ? May 11, 2021 ? Sientra, Inc. (NASDAQ: SIEN) (?Sientra? or the ?Company?), a medical aesthetics company uniquely focused on plastic surgeons, today announced it has entered into a definitive agreement to sell its miraDry b
May 11, 2021	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36709 SIENTRA,
May 11, 2021	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 11, 2021 SIENTRA, INC. (Exact name of registrant as specified in its charter) Commission File Number: 001-36709 Delaware 20-5551000 (State or other jurisdiction of incorporation)
May 11, 2021	S-8	- S-8 As filed with the Securities and Exchange Commission on May 11, 2021 Registration No.
May 11, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 11, 2021 SIENTRA, INC.
April 28, 2021	DEF 14A	- DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14
April 28, 2021	DEFA14A	- DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin
March 11, 2021	EX-10.1	Employment Agreement, dated September 18, 2017, by and between the Company and Valerie Miller. Exhibit 10.1 SIENTRA, INC. EMPLOYMENT AGREEMENT VALERIE MILLER This Employment Agreement (the ?Agreement?), made between Sientra, Inc. (the ?Company?) and Valerie Miller (?Employee?) (collectively, the ?Parties?), is effective as of September 18, 2017 (the ?Effective Date?). WHEREAS, the Company desires to employ Employee, pursuant to the terms, provisions and conditions set forth in this Agreemen
March 11, 2021	EX-99.1	Sientra Reports Fourth Quarter and Full Year 2020 Financial Results Exhibit 99.1 Sientra Reports Fourth Quarter and Full Year 2020 Financial Results Santa Barbara, CA – March 11, 2021 – Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced its audited financial results for the fourth quarter and full year ended December 31, 2020. Ron Menezes, President and Chief Executive Offic
March 11, 2021	10-K	Annual Report - 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-36709 SIENTRA, INC. (Exact Name of Registrant as Speci
March 11, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 11, 2021 SIENTRA, INC.
March 11, 2021	EX-4.3	Description of the Company’s securities Exhibit 4.3 DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Sientra, Inc. (?Sientra,? ?we,? ?our,? or ?us?) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: our common stock. DESCRIPTION OF CAPITAL STOCK The following summary of the terms of our capital stock is based upon
March 11, 2021	EX-21.1	List of significant subsidiaries of the registrant. Exhibit 21.1 Subsidiaries Subsidiary Jurisdiction miraDry Holdings, Inc. Delaware miraDry, Inc. Delaware miraDry International, Inc. Delaware Miramar Labs HK Ltd. Hong Kong miraDry International Sweden AB Sweden
March 11, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 9, 2021 SIENTRA, INC. (Exact name of registrant as specified in its charter) Delaware 001-36709 20-5551000 (State or other jurisdiction of incorporation) (Commission File Number
February 16, 2021	SC 13G/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO. 2) SIENTRA, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.01 PER SHARE (Title of Class of Securities) 826 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO. 2) SIENTRA, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.01 PER SHARE (Title of Class of Securities) 82621J105 (CUSIP Number) DECEMBER 31, 2020 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursua
February 12, 2021	SC 13G/A	Sientra, Inc. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Sientra, Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 82621J105 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to which this Sche
February 12, 2021	SC 13G/A	SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 3)* Sientr SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No.
February 10, 2021	SC 13G	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name of issuer: Sientra Inc. Title of Class of Securities: Common Stock CUSIP Number: 82621J105 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d-1(b) ☐ Rule 13d-1
February 9, 2021	EX-1.1	Underwriting Agreement, dated February 8, 2021, by and between Sientra, Inc. and Stifel, Nicolaus & Company, Incorporated Exhibit 1.1 5,410,628 Shares SIENTRA, INC. Common Stock UNDERWRITING AGREEMENT February 8, 2021 STIFEL, NICOLAUS & COMPANY, INCORPORATED As representative of the Underwriters named in Schedule I hereto c/o Stifel, Nicolaus & Company, Incorporated One Montgomery Street, Suite 3700 San Francisco, CA 94104 Ladies and Gentlemen: Sientra, Inc., a Delaware corporation (the “Company”), proposes to issue
February 9, 2021	EX-99.2	Sientra Announces Pricing of Public Offering of Common Stock EX-99.2 Exhibit 99.2 Sientra Announces Pricing of Public Offering of Common Stock Santa Barbara, CA – February 8, 2021 – Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced the pricing of its previously announced underwritten public offering. The Company will sell 5,410,628 shares of its common stock at a pub
February 9, 2021	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 8, 2021 SIENTRA, INC. (Exact name of registrant as specified in its charter) Commission File Number: 001-36709 Delaware 20-5551000 (State or other jurisdiction of incorporati
February 9, 2021	424B5	5,410,628 Shares Common Stock 424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-231288 PROSPECTUS SUPPLEMENT (To prospectus dated May 22, 2019) 5,410,628 Shares Common Stock We are offering 5,410,628 of shares of our common stock. Our common stock is listed on the Nasdaq Global Select Market under the symbol “SIEN.” On February 8, 2021, the last reported sale price of our common stock on the Nasdaq
February 9, 2021	EX-99.1	Sientra Commences Public Offering of Common Stock EX-99.1 Exhibit 99.1 Sientra Commences Public Offering of Common Stock Santa Barbara, CA – February 8, 2021 – Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced that it has commenced an underwritten public follow-on offering of its common stock to be sold by the Company. In addition, the Company intends to g
February 8, 2021	424B5	SUBJECT TO COMPLETION, DATED FEBRUARY 8, 2021 424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-231288 SUBJECT TO COMPLETION, DATED FEBRUARY 8, 2021 The information in this preliminary prospectus supplement is not complete and may be changed. Neither this preliminary prospectus supplement nor the accompanying prospectus is an offer to sell these securities, and we are not soliciting an offer to buy these securities
February 8, 2021	S-3MEF	- S-3MEF As filed with the Securities and Exchange Commission on February 8, 2021 Registration No.
February 8, 2021	EX-10.1	Second Amended and Restated Credit and Security Agreement (Term Loan), dated February 5, 2021 by and among Sientra, Inc., certain of its wholly-owned subsidiaries, the lenders party thereto from time to time and MidCap Financial Trust, as administrative agent and collateral agent. EX-10.1 CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. Exhibit 10.1 Execution Version SECOND AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (TERM LOAN) dated as of February 5, 2021 by and among SIENTRA, INC., MIRADRY HOLDINGS, INC., MIRADRY, INC., MIRADRY INTERNAT
February 8, 2021	EX-10.2	Third Amendment to Amended and Restated Credit and Security Agreement (Revolving Loan), dated February 5, 2021 by and among Sientra, Inc., certain of its wholly-owned subsidiaries, the lenders party thereto from time to time and MidCap Financial Trust, as administrative agent and collateral agent. EX-10.2 CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. Exhibit 10.2 Execution Version THIRD AMENDMENT TO AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (REVOLVING LOAN) This THIRD AMENDMENT TO AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (REVOLVING LOAN) (th
February 8, 2021	8-K	Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2021 SIENTRA, INC. (Exact name of registrant as specified in its charter) Delaware 001-36709 20-5551000 (State or other jurisdiction of incorporation) (Commission File Num
February 4, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 4, 2021 SIENTRA, INC. (Exact name of registrant as specified in its charter) Delaware 001-36709 20-5551000 (State or other jurisdiction of incorporation) (Commission File Num
February 4, 2021	EX-99.1	Sientra Reports Preliminary Fourth Quarter and Full Year 2020 Results Estimates highest ever Breast Products segment net sales of $17.9 million, representing 40% year over year growth Results driven by Sientra’s continued investment and market outper EX-99.1 Exhibit 99.1 Sientra Reports Preliminary Fourth Quarter and Full Year 2020 Results Estimates highest ever Breast Products segment net sales of $17.9 million, representing 40% year over year growth Results driven by Sientra’s continued investment and market outperformance in the core breast products segment Santa Barbara, CA – February 04, 2021 – Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or t
November 12, 2020	EX-10.1	Employment Agreement, dated November 9, 2020, by and between the Company and Ronald Menezes. Exhibit 10.1 SIENTRA, INC. EMPLOYMENT AGREEMENT Ronald Menezes This Executive Employment Agreement (the ?Agreement?), made between Sientra, Inc., a Delaware company headquartered in Santa Barbara, CA(the ?Company?) and Ronald Menezes (?Executive?) (collectively, the ?Parties?), shall be effective as of the 10th day of November, 2020 (the ?Effective Date?). WHEREAS, the Company desires to employ Ex
November 12, 2020	EX-10.3	Employment Agreement, dated November 9, 2020, by and between the Company and Caroline Van Hove. Exhibit 10.3 SIENTRA, INC. EMPLOYMENT AGREEMENT Caroline Van Hove This Executive Employment Agreement (the ?Agreement?), made between Sientra, Inc., a Delaware company headquartered in Santa Barbara, CA (the ?Company?) and Caroline Van Hove (?Executive?) (collectively, the ?Parties?), shall be effective as of the 9th day of November, 2020 (the ?Effective Date?). WHEREAS, the Company desires to emp
November 12, 2020	EX-10.2	Separation Agreement, dated November 9, 2020, by and between the Company and Jeffrey M. Nugent. Exhibit 10.2 November 9, 2020 Jeffrey M. Nugent Address on file RE: Separation Agreement Dear Jeff, This letter sets forth the terms and conditions of our agreement (the ?Agreement?) regarding the separation of your employment with Sientra, Inc. (the ?Company?). This Agreement will become effective on the ?Effective Date? as defined in Section 11 herein. You and the Company hereby agree as follows
November 12, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2020 SIENTRA, INC. (Exact name of registrant as specified in its charter) Delaware 001-36709 20-5551000 (State or other jurisdiction of incorporation) (Commission File Num
November 12, 2020	EX-99.1	Sientra Appoints Ron Menezes as President and Chief Executive Officer Jeffrey Nugent, Current Chairman and Chief Executive Officer, Announces His Retirement Caroline Van Hove, Aesthetics Leader and Current Sientra Director, Succeeds Nugent as Executi Exhibit 99.1 Sientra Appoints Ron Menezes as President and Chief Executive Officer Jeffrey Nugent, Current Chairman and Chief Executive Officer, Announces His Retirement Caroline Van Hove, Aesthetics Leader and Current Sientra Director, Succeeds Nugent as Executive Chair of Board of Directors Santa Barbara, CA ? November 9, 2020 ? Sientra, Inc. (NASDAQ: SIEN) (?Sientra? or the ?Company?), a global
November 9, 2020	10-Q	Quarterly Report - 10-Q 18 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36709 SI
November 9, 2020	EX-99.1	Sientra Reports Third Quarter 2020 Financial Results Reports record Breast Products net sales of $15.3 million, representing 54% sequential growth and 21% year over year growth Results driven by U.S. recovery and market outperformance in the core bre Exhibit 99.1 Sientra Reports Third Quarter 2020 Financial Results Reports record Breast Products net sales of $15.3 million, representing 54% sequential growth and 21% year over year growth Results driven by U.S. recovery and market outperformance in the core breast products segment Santa Barbara, CA ? November 09, 2020 ? Sientra, Inc. (NASDAQ: SIEN) (?Sientra? or the ?Company?), a diversified med
November 9, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 9, 2020 SIENTRA, INC.
October 7, 2020	SC 13G	SIEN / Sientra, Inc. / Granite Point Capital Management, L.P. - SIENTRA, INC. Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Sientra, Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 82621J105 (CUSIP Number) May 18, 2020 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is
August 25, 2020	EX-99.1	Sientra Receives Regulatory Approval to Market OPUS® Breast Implants in Japan Marks First Regulatory approval of Sientra Breast Implants Outside of the U.S. EX-99.1 Exhibit 99.1 Sientra Receives Regulatory Approval to Market OPUS® Breast Implants in Japan Marks First Regulatory approval of Sientra Breast Implants Outside of the U.S. Santa Barbara, CA – August 25, 2020 – Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a diversified global medical aesthetics company, announced today that it has received approval from Japan’s Pharmaceutical an
August 25, 2020	8-K	Financial Statements and Exhibits, Other Events - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 25, 2020 SIENTRA, INC. (Exact name of registrant as specified in its charter) Delaware 001-36709 20-5551000 (State or other jurisdiction of incorporation) (Commission File Numb
August 10, 2020	EX-99.1	Sientra Reports Second Quarter 2020 Financial Results Continued Strength in Core Breast Products Business Despite COVID-19 Headwinds Demonstrated Results Through “Drive the Recovery” Practice Initiatives High-Margin miraDry bioTip® Consumable Model I Exhibit 99.1 Sientra Reports Second Quarter 2020 Financial Results Continued Strength in Core Breast Products Business Despite COVID-19 Headwinds Demonstrated Results Through “Drive the Recovery” Practice Initiatives High-Margin miraDry bioTip® Consumable Model Implemented Santa Barbara, CA – August 10, 2020 – Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a diversified medical aesthet
August 10, 2020	10-Q	Quarterly Report - 10-Q 18 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36709 SIENTRA
August 10, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 10, 2020 SIENTRA, INC.
August 10, 2020	EX-10.5	Employment Agreement, dated January 1, 2018, by and between Sientra, Inc. and Oliver Bennett. Exhibit 10.5 SIENTRA, INC. EMPLOYMENT AGREEMENT OLIVER BENNETT This Employment Agreement (the “Agreement”), made between Sientra, Inc. (the “Company”) and Oliver Bennett (“Employee”) (collectively, the “Parties”), is effective as of January 1, 2018 (the “Effective Date”). WHEREAS, the Company desires to employ Employee, pursuant to the terms, provisions and conditions set forth in this Agreement;
June 9, 2020	8-K	Submission of Matters to a Vote of Security Holders Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2020 SIENTRA, INC. (Exact name of registrant as specified in its charter) Delaware 001-36709 20-5551000 (State or other jurisdiction of incorporation) (Commission Fil
May 11, 2020	EX-10.5	Letter Agreement, dated April 20, 2020, by and among Sientra, Inc., certain of its subsidiaries, MidCap Financial Trust and MidCap Funding IV Trust Exhibit 10.5 c/o MidCap Financial Services, LLC, as Servicer 7255 Woodmont Avenue, Suite 200 Bethesda, MD 20814 www.midcapfinancial.com April 20, 2020 VIA EMAIL Paul Little Chief Financial Officer Sientra, Inc. 420 South Fairview Santa Barbara, CA 93117 RE:Proposed SBA Loan 1 Dear Paul: We refer to that certain Credit and Security Agreement dated as of July 25, 2017 (as amended, modified, suppleme
May 11, 2020	EX-10.4	Amendment to Facility Agreement, dated April 24, 2020, by and among Sientra, Inc., each of the other loan parties thereto and Deerfield Partners, L.P. Exhibit 10.4 AMENDMENT TO FACILITY AGREEMENT This AMENDMENT TO FACILITY AGREEMENT (this “Agreement”), dated as of April 24, 2020, is entered into among SIENTRA, INC., a Delaware corporation (the “Borrower”), each of the other Loan Parties party hereto, and DEERFIELD PARNTERS, L.P., as a Lender (as defined below) and as agent (in such capacity, the “Agent”). RECITALS WHEREAS, the Borrower, the Loan
May 11, 2020	EX-10.6	Second Amendment to Amended and Restated Credit and Security Agreement (Term Loan), dated May 11, 2020, by and among Sientra, Inc., certain of its subsidiaries, the lenders party thereto and MidCap Financial Trust. Exhibit 10.6 Portions of this Exhibit have been redacted pursuant to a request for confidential treatment under Rule 406 of the Securities Act of 1933, as amended. Such redacted portions have been with “[***]” in this Exhibit. An unredacted copy of this document has been filed separately with the Securities and Exchange Commission. Execution Version SECOND amendment TO AMENDED AND RESTATED CREDIT
May 11, 2020	EX-99.1	Sientra Reports First Quarter 2020 Financial Results Strong Q1 Breast Products Performance Despite COVID-19 Headwinds Strengthened Focus on Core Breast Products Business and High-Margin bioTip® Sales to Drive Profitability and Growth Exhibit 99.1 Sientra Reports First Quarter 2020 Financial Results Strong Q1 Breast Products Performance Despite COVID-19 Headwinds Strengthened Focus on Core Breast Products Business and High-Margin bioTip® Sales to Drive Profitability and Growth Q1 2020 & Recent Highlights: • Q1 total net sales of $16.9 million, a 4% decrease year-over-year • Breast Products Q1 net sales of $12.5 million, growth
May 11, 2020	EX-10.7	Second Amendment to Amended and Restated Credit and Security Agreement (Revolving Loan), dated May 11, 2020, by and among Sientra, Inc., certain of its subsidiaries, the lenders party thereto and MidCap Financial Trust. Exhibit 10.7 Portions of this Exhibit have been redacted pursuant to a request for confidential treatment under Rule 406 of the Securities Act of 1933, as amended. Such redacted portions have been with “[***]” in this Exhibit. An unredacted copy of this document has been filed separately with the Securities and Exchange Commission. Execution Version SECOND amendment TO AMENDED AND RESTATED CREDIT
May 11, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 11, 2020 SIENTRA, INC.
May 11, 2020	10-Q	Quarterly Report - 10-Q 18 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36709 SIENTR
May 6, 2020	CORRESP	- CORRESP May 6, 2020 Via EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549-4561 Attn: Ms.
May 6, 2020	CORRESP	- CORRESP May 6, 2020 Via EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549-4561 Attn: Ms.
April 22, 2020	DEF 14A	definitive proxy statement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin
April 22, 2020	DEFA14A	SIEN / Sientra, Inc. DEFA14A - - DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a‑6(e)(2)) ☐ Defin
April 10, 2020	S-8	File No. 333-237641 As filed with the Securities and Exchange Commission on April 10, 2020 Registration No.
April 10, 2020	S-3	SIEN / Sientra, Inc. S-3 - - S-3 S-3 Table of Contents As filed with the Securities and Exchange Commission on April 10, 2020 Registration No.
April 10, 2020	S-3/A	SIEN / Sientra, Inc. S-3/A - - S-3/A S-3/A Table of Contents As filed with the Securities and Exchange Commission on April 10, 2020 Registration No.
April 7, 2020	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 1, 2020 SIENTRA, INC. (Exact name of registrant as specified in its charter) Delaware 001-36709 20-5551000 (State or other jurisdiction of incorporation) (Commission File Number
March 16, 2020	10-K	Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-36709 SIENTRA, INC. (Exact Name of Registrant as Speci
March 16, 2020	EX-10.38	Limited Consent and First Amendment to Amended and Restated Credit and Security Agreement (Term Loan), dated November 7, 2019 by and among Sientra, Inc., certain of its wholly-owned subsidiaries, the lenders party thereto from time to time and MidCap Financial Trust, as administrative agent and collateral agent. Exhibit 10.38 LIMITED CONSENT and first amendment TO AMENDED AND RESTATED to CREDIT AND SECURITY AGREEMENT (TERM LOAN) This LIMITED CONSENT AND FIRST AMENDMENT TO AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (TERM LOAN) (this “Agreement”) is made as November [●], 2019, by and among SIENTRA, INC., a Delaware corporation, MIRADRY HOLDINGS, INC., a Delaware corporation (formerly known as Mirama
March 16, 2020	EX-10.39	Limited Consent and First Amendment to Amended and Restated Credit and Security Agreement (Revolving Loan), dated November 7, 2019 by and among Sientra, Inc., certain of its wholly-owned subsidiaries, the lenders party thereto from time to time and MidCap Financial Trust, as administrative agent and collateral agent. Exhibit 10.39 LIMITED CONSENT and first amendment TO AMENDED AND RESTATED to CREDIT AND SECURITY AGREEMENT (REVOLVING LOAN) This LIMITED CONSENT AND FIRST AMENDMENT TO AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (REVOLVING LOAN) (this “Agreement”) is made as November 7, 2019, by and among SIENTRA, INC., a Delaware corporation, MIRADRY HOLDINGS, INC., a Delaware corporation (formerly known a
March 16, 2020	EX-21.1	List of significant subsidiaries of the registrant. Exhibit 21.1 Subsidiaries Subsidiary Jurisdiction miraDry Holdings, Inc. Delaware miraDry, Inc. Delaware miraDry International, Inc. Delaware Miramar Labs HK Ltd. Hong Kong miraDry International Sweden AB Sweden
March 16, 2020	EX-4.3	Exhibit 4.3 Exhibit 4.3 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Sientra, Inc. (“Sientra,” “we,” “our,” or “us”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: our common stock. DESCRIPTION OF CAPITAL STOCK The following summary of the terms of our capital stock is based upon
March 16, 2020	EX-10.40	Facility Agreement, dated as of March 11, 2020, by and among Sientra, Inc., certain of Sientra, Inc.’s subsidiaries party thereto as guarantors and Deerfield Partners, L.P Exhibit 10.40 EXECUTION VERSION FACILITY AGREEMENT dated as of March 11, 2020 by and among SIENTRA, INC., as the Borrower, the other Loan Parties party hereto from time to time, the Lenders and DEERFIELD PARTNERS, L.P., as agent for itself and the Lenders Table of Contents ARTICLE 1 DEFINITIONS 1 Section 1.1 General Definitions 1 Section 1.2 Interpretation 21 Section 1.3 Business Day Adjustment 22
March 12, 2020	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 11, 2020 SIENTRA, INC. (Exact name of registrant as specified in its charter) Delaware 001-36709 20-5551000 (State or other jurisdiction of incorporation) (Commission File N
March 12, 2020	EX-10.3	Registration Rights Agreement, dated as of March 11, 2020, by and between Sientra, Inc. and Deerfield Partners, L.P. EX-10.3 Exhibit 10.3 EXECUTION VERSION REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of March 11, 2020, is entered into by and among Sientra, Inc., a Delaware corporation (the “Company”), and Deerfield Partners, L.P. (the “Closing Date Lender”). WHEREAS: A. In connection with the Facility Agreement, of even date herewith (the “Facility Agreement”), b
March 12, 2020	EX-99.1	Sientra Announces $60 Million Convertible Notes Investment from Deerfield Management New Financing Provides Enhanced Financial Flexibility to Execute on Strategic Priorities as Sientra Continues on Path to Aesthetics Market Leadership EX-99.1 Exhibit 99.1 Sientra Announces $60 Million Convertible Notes Investment from Deerfield Management New Financing Provides Enhanced Financial Flexibility to Execute on Strategic Priorities as Sientra Continues on Path to Aesthetics Market Leadership Santa Barbara, CA – March 11, 2020 – Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a diversified medical aesthetics company, today
March 12, 2020	EX-10.1	Facility Agreement, dated as of March 11, 2020, by and among Sientra, Inc., certain of Sientra, Inc.’s subsidiaries party thereto as guarantors and Deerfield Partners, L.P. EX-10.1 Exhibit 10.1 EXECUTION VERSION FACILITY AGREEMENT dated as of March 11, 2020 by and among SIENTRA, INC., as the Borrower, the other Loan Parties party hereto from time to time, the Lenders and DEERFIELD PARTNERS, L.P., as agent for itself and the Lenders Table of Contents ARTICLE 1 DEFINITIONS 1 Section 1.1 General Definitions 1 Section 1.2 Interpretation 21 Section 1.3 Business Day Adjust
March 12, 2020	EX-10.2	Guaranty, dated as of March 11, 2020, by and among MiraDry Holdings, Inc., MiraDry, Inc. and MiraDry International, Inc. EX-10.2 Exhibit 10.2 EXECUTION VERSION GUARANTY GUARANTY (this “Guaranty”), dated as of March 11, 2020, by each of the undersigned Subsidiaries of the Borrower (as defined below) (each such Person, individually, a “Guarantor” and, collectively, the “Guarantors”) in favor of (i) Deerfield Partners, L.P., as agent (in such capacity, the “Agent”) for its own benefit and the benefit of other Lenders,
March 12, 2020	EX-4.1	Form of Convertible Note. EX-4.1 Exhibit 4.1 EXECUTION VERSION THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER SAID ACT, OR PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER SAID ACT IN
March 11, 2020	EX-99.1	Sientra Reports Fourth Quarter and Full Year 2019 Financial Results Achieves Record Fourth Quarter Net Sales and Strong Growth Across Both Business Segments Well-Capitalized Balance Sheet Provides Enhanced Flexibility to Execute on Strategic Initiati Exhibit 99.1 Sientra Reports Fourth Quarter and Full Year 2019 Financial Results Achieves Record Fourth Quarter Net Sales and Strong Growth Across Both Business Segments Well-Capitalized Balance Sheet Provides Enhanced Flexibility to Execute on Strategic Initiatives Q4 and Full Year 2019 Highlights: • Record Q4 total net sales of $23.2 million, growth of 22% year-over-year • Breast Products Q4 net
March 11, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 11, 2020 SIENTRA, INC.
February 14, 2020	EX-99.3	POWER OF ATTORNEY Power of Attorney EXHIBIT 3 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, THAT: The undersigned, Waddell & Reed Financial, Inc.
February 14, 2020	EX-99.2	EXHIBIT 2 Identification and Classification of the Subsidiary Which Acquired the Security EXHIBIT 2 Ivy Investment Management Company - Tax ID No. 03-0481447 Investment Advisor registered under Section 203 of the Investment Advisors Act of 1940
February 14, 2020	SC 13G/A	SIEN / Sientra, Inc. / WADDELL & REED FINANCIAL INC - SIENTRA, INC. Passive Investment Sientra, Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Amendment No. 1* Sientra, Inc (Name of Issuer) Common Stock (Title of Class of Securities) 82621J105 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which thi
February 14, 2020	EX-99.1	JOINT FILING AGREEMENT Joint Filing Agreement EXHIBIT 1 JOINT FILING AGREEMENT Waddell & Reed Financial, Inc.
February 13, 2020	SC 13G/A	SIEN / Sientra, Inc. / Flynn James E Passive Investment SC 13G/A 1 e619372sc13ga-sientra.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 2)* Sientra, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 82621J105 (CUSIP Number) December 31, 2019 (
January 21, 2020	SC 13G/A	SIEN / Sientra, Inc. / INTEGRATED CORE STRATEGIES (US) LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO. 1) SIENTRA, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.01 PER SHARE (Title of Class of Securities) 82621J105 (CUSIP Number) DECEMBER 31, 2019 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursua
January 17, 2020	CORRESP	- CORRESP DLA Piper LLP (US) 4365 Executive Drive, Suite 1100 San Diego, California 92121-2133 www.
January 13, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2020 SIENTRA, INC. (Exact name of registrant as specified in its charter) Delaware 001-36709 20-5551000 (State or other jurisdiction of incorporation) (Commission File
January 13, 2020	EX-99.1	Sientra Announces Preliminary Unaudited 4Q19 Net Sales and Appointment of Caroline Van Hove to Board of Directors Anticipates total fourth quarter net sales of $23.2 million, growth of 22% year over year Aesthetics industry executive Caroline Van Hov EX-99.1 Exhibit 99.1 Sientra Announces Preliminary Unaudited 4Q19 Net Sales and Appointment of Caroline Van Hove to Board of Directors Anticipates total fourth quarter net sales of $23.2 million, growth of 22% year over year Aesthetics industry executive Caroline Van Hove joins Sientra’s Board of Directors Santa Barbara, CA – January 13, 2020 – Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics co
December 23, 2019	S-3	Power of Attorney (included immediately following the signature page to the registration statement) S-3 Table of Contents As filed with the Securities and Exchange Commission on December 23, 2019 Registration No.
November 15, 2019	EX-10.1	First Amendment to Lease Agreement, effective as of November 1, 2019, by and between Sientra, Inc. and Fairview Business Associates, LLC. EX-10.1 Exhibit 10.1 FIRST AMENDMENT TO LEASE AGREEMENT This First Amendment to Lease Agreement (“this Amendment”) is made as of November 1, 2019 (“First Amendment Effective Date”), between SIENTRA, INC., a Delaware corporation (“Tenant”), and FAIRVIEW BUSINESS ASSOCIATES, LLC, a California limited liability company (“Landlord”). RECITALS A. Landlord, by and through its predecessor in interest Fai
November 15, 2019	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 11, 2019 SIENTRA, INC.
November 7, 2019	EX-10.2	Amended and Restated Manufacturing and Supply Agreement, dated November 7, 2019, by and between Sientra, Inc. and Vesta Intermediate Funding, Inc. Exhibit 10.2 Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed, and has been marked with a “[***]” where the information has been omitted from the filed version of the exhibit. Page 1 of 39 AMENDED AND RESTATED MANUFACTURING AND SUPPLY AGREEMENT (LZ# G1651852) This AMENDED AND RESTATED
November 7, 2019	EX-10.1	Confidential Settlement, Release and Consulting Agreement, dated November 4, 2019, by and between Sientra, Inc. and Charles Huiner. Exhibit 10.1 CONFIDENTIAL SETTLEMENT, RELEASE AND CONSULTING AGREEMENT This CONFIDENTIAL SETTLEMENT, RELEASE AND CONSULTING AGREEMENT (the “Agreement”) is made effective on November 1, 2019, by and between Sientra, Inc. (the “Company”) and Charlie Huiner (“You” or “Your”). 1. Separation. As of September 30, 2019 (the “Separation Date”), Your responsibilities as Chief Operating Officer & Senior Vic
November 7, 2019	10-Q	September 30, 2019 f 18 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36709
November 7, 2019	EX-10.3	Master Supply Agreement, dated November 7, 2019, by and between Sientra, Inc. and NuSil Technology LLC. Exhibit 10.3 Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed, and has been marked with a “[***]” where the information has been omitted from the filed version of the exhibit. MASTER SUPPLY AGREEMENT THIS SUPPLY AGREEMENT (the “Agreement”) is made effective as of the date last signed
November 7, 2019	EX-10.1	Asset Purchase Agreement, dated November 7, 2019, by and between Sientra, Inc. and Vesta Intermediate Funding, Inc. EX-10.1 Exhibit 10.1 Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed, and has been marked with a “[***]” where the information has been omitted from the filed version of the exhibit. ASSET PURCHASE AGREEMENT by and between SIENTRA, INC., as Purchaser, and VESTA INTERMEDIATE FUNDING,
November 7, 2019	EX-10.2	Lease, dated November 7, 2019, by and between Sientra, Inc. and Vesta Intermediate Funding, Inc. EX-10.2 Exhibit 10.2 Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed, and has been marked with a “[***]” where the information has been omitted from the filed version of the exhibit.. 9900 South 57th Street Franklin, Wisconsin LANDLORD VESTA INTERMEDIATE FUNDING, INC. TENANT SIENTRA,
November 7, 2019	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 7, 2019 SIENTRA, INC.
November 7, 2019	EX-99.1	Sientra Reports Third Quarter 2019 Financial Results Exhibit 99.1 Sientra Reports Third Quarter 2019 Financial Results Highlights: • Record total net sales of $22.4 million in 3Q19, growth of 33% year over year • Breast Products net sales of $12.6 million in 3Q19, growth of 47% year over year • Record miraDry net sales of $9.8 million in 3Q19, growth of 18% year over year • Increases 2019 total net sales outlook to $82.5-$83.5 million from $79-$83 m
November 7, 2019	8-K	Financial Statements and Exhibits, Costs Associated with Exit or Disposal Activities, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 7, 2019 SIENTRA, INC.
October 3, 2019	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 3, 2019 SIENTRA, INC. (Exact name of registrant as specified in its charter) Delaware 001-36709 20-5551000 (State or other jurisdiction of incorporation) (Commission File
August 16, 2019	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 13, 2019 SIENTRA, INC. (Exact name of registrant as specified in its charter) Delaware 001-36709 20-5551000 (State or other jurisdiction of incorporation) (Commission File
August 9, 2019	8-K/A	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Amendment No.
August 9, 2019	EX-99.1	Sientra Reports Second Quarter 2019 Financial Results Record total net sales of $20.5 million in 2Q19, growth of 17% year over year Breast Products net sales of $11.2 million in 2Q19, growth of 19% year over year Record miraDry net sales of $9.3 mill EX-99.1 Exhibit 99.1 Sientra Reports Second Quarter 2019 Financial Results Record total net sales of $20.5 million in 2Q19, growth of 17% year over year Breast Products net sales of $11.2 million in 2Q19, growth of 19% year over year Record miraDry net sales of $9.3 million in 2Q19, growth of 15% year over year Reiterates 2019 total net sales outlook of $79 to $83 million Santa Barbara, CA – Augus
August 9, 2019	EX-10.3	Amended and Restated Credit and Security Agreement (Revolving Loan), dated July 1, 2019 by and among Sientra, Inc., certain of its wholly-owned subsidiaries, the lenders party thereto from time to time and MidCap Financial Trust, as administrative agent and collateral agent. Exhibit 10.3 Execution Version AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (REVOLVING LOAN) dated as of July 1, 2019 by and among SIENTRA, INC., MIRADRY HOLDINGS, INC., MIRADRY, INC., MIRADRY INTERNATIONAL, INC., and any additional borrower that hereafter becomes party hereto, each as Borrower, and collectively as Borrowers, and MIDCAP FUNDING IV TRUST, as Agent and as a Lender, and THE ADD
August 9, 2019	10-Q	June 30, 2019 f 18 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36709 SIENT

SIEN / Sientra, Inc. - SEC-arkivering, Årsberetning, Fuldmagtserklæring

Grundlæggende statistik

SEC Filings

SEC Filings (Chronological Order)